Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iniparib with Gemcitabine/Carboplatin in Squamous NSCLC
NCT01082549Phase 3Completed
- Sponsor
- Sanofi
- Start
- Mar 2010
- Primary completion
- Apr 2013
- Modality
- Small Molecules
- Countries
- 14
01
Overview
A Phase 3 trial of iniparib in squamous cell carcinoma of the lung (LSCC), sponsored by Sanofi. Started Mar 2010; status: completed.
02
Drugs
iniparib
03
Conditions
squamous cell carcinoma of the lung (LSCC)
Beyond the preview
Go deeper on NCT01082549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01082549.